Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel
NCT06692933Phase 1Recruiting
- Sponsor
- Washington State University
- Start
- Jun 2024
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of cannabidiol (3 arms), sponsored by Washington State University. Primary endpoint: Area Under the Curve ratio of clopidogrel active metabolite. Started Jun 2024; status: recruiting.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on NCT06692933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06692933.